Key result
CPET guides risk evaluation, treatment response, and rehabilitation in PAH.
Why the study?
What is the role of cardiopulmonary exercise testing and rehabilitation in the evaluation and management of patients with pulmonary artery hypertension?
What is the role of cardiopulmonary exercise testing and rehabilitation in the evaluation and management of patients with pulmonary artery hypertension?
Answers are grounded in this paper and cite their sources.
Cardiopulmonary exercise testing is a valuable tool for assessing risk status, evaluating treatment response, and guiding rehabilitation programs in patients with pulmonary artery hypertension.
Pulmonary artery hypertension (PAH) is a rare but lethal disease that affects the pulmonary vascular bed, resulting in hypoxia, respiratory distress, right heart failure, exercise limitation and mortality. Currently, many PAH specific medications are applied to ameliorate patients' symptoms, improve life quality and prolong their lives. The survival rate has improved with medical therapy but patients may still suffer from insufficient exercise capacity. Therefore, cardiopulmonary exercise test (CPET) can play an important role in the evaluation of PAH patients' risk status and treatment response, and, furthermore, it can guide the rehabilitation program. In this article, we would like to introduce the current implementation of CPET and rehabilitation for PAH patients.
No takes yet. Share an insight, caveat, or question.
Chiu et al. (2022) conducted a review in Pulmonary artery hypertension (PAH). Cardiopulmonary exercise test (CPET) and rehabilitation was evaluated. Cardiopulmonary exercise testing plays an important role in evaluating risk status and treatment response, and guiding rehabilitation programs for patients with pulmonary artery hypertension.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: